4//SEC Filing
AUERBACH ALAN H 4
Accession 0001437749-24-023014
CIK 0001401667other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 6:50 PM ET
Size
5.2 KB
Accession
0001437749-24-023014
Insider Transaction Report
Form 4
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2024-07-17$3.70/sh−21,920$81,128→ 7,063,515 total
Footnotes (2)
- [F1]Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001358285
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 6:50 PM ET
- Size
- 5.2 KB